Skip to content

8-KAccepted Oct 20, 5:00 PM ET

RVL Pharmaceuticals plc 8-K

RVL Pharmaceuticals plc

Accepted (ET)

5:00 PM

Oct 20, 2023

Filed

Oct 20, 2023

Documents

13

Size

1.2 MB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.